Clinical practice in type 2 diabetes: After metformin and lifestyle, then what?

This activity was supported by an educational grant from Takeda Pharmaceuticals North American, Inc., and was submitted by the Primary Care Education Consortium.

Matching patient-specific characteristics and disease pathophysiology to therapeutic choices can improve outcomes for patients with type 2 diabetes mellitus (T2DM). This supplement teaches clinicians to work with patients to help them understand the importance of lifestyle modification, and that T2DM is a progressive disease that may require changes in therapy.

Online only: Table 2: Profile of current antihyperglycemic therapies

Full text | PDF